Clinical Trial Update: Clinical and Radiographic Evaluation of Hyaluronic Acid (Gengigel Teething) Versus Mineral Trioxide Aggregate( Angelus) as Pulpotomy Agent in Vital Primary Molars [Phase 1]

View source ↗

Summary

Phase 1 clinical trial at Cairo University comparing hyaluronic acid (Gengigel Teething) with mineral trioxide aggregate (Angelus) as pulpotomy agents in vital …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dental Pulp Disease
• Pulpitis

Drugs mentioned

• Gengigel Teething (Hyaluronic acid)
• MTA Angelus (Mineral Trioxide Aggregate)

Snippet

Sponsor: Cairo University | Conditions: Pulpotomies Primary Teeth, Pulp Disease, Dental | Phase 1 | Status: NOT_YET_RECRUITING